← All trials
NCT00678613
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2007
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 250
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- All India Institute of Medical SciencesLead sponsor
- All India Institute of Medical SciencesOverall official - principal investigator
Drugs studied
- norfloxacin
- norfloxacin
- bifidobacterium infantis
- bifidobacterium infantis
- bifidobacterium breve
- bifidobacterium breve
- bifidobacterium longum
- bifidobacterium longum
- lactobacillus plantarum
- lactobacillus plantarum
- vsl #3
- vsl #3
- streptococcus salivarius
- streptococcus salivarius
- Lactobacillus acidophilus
- Lactobacillus acidophilus
- lactobacillus casei
- lactobacillus casei
- lactobacillus delbrueckii
- lactobacillus delbrueckii
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.